In My Hero Academia, being a Pro Hero isn’t just about strength or strategy, it’s also about presentation. The right outfit ...

Elon Musk's X is launching XChat in beta with encryption, vanishing messages, and file sharing. XChat aims to enhance privacy on X, aligning with Musk's vision for an everything app. XChat's ...

X, formerly known as Twitter, briefly experienced serious malfunctions for thousands of users Friday. Many users accessing X suddenly saw their entire feeds disappear, and the ability to post ...

Social media platform X, formerly known as Twitter, was briefly inaccessible for thousands of US users early Saturday, according to Downdetector.com, which tracks internet disruptions. The site ...

For over 24 hours, many X users, including this reporter, have been experiencing issues with the site’s basic functionality. Some messages won’t load, timelines won’t update, and certain ...

The Tenya restaurant chain opened its first restaurant in September 1989, in the Yaesu underground shopping mall at Tokyo Station, Japan. “The opening drew extraordinary attention, with queues ...

Fujifilm X-E5 rumored to be launching in June News comes four years after the release of the X-E4 X-E4 received mixed reviews for its minimalist approach With retro looks and tactile controls ...

It wasn't until "Fight on, Iida" concluded that I realized the title isn't merely a reference to Tenya, but the entire Iida family. My Hero Academia has done an excellent job of working in the ...

Elon Musk on Friday evening announced he has sold his social media company, X, to xAI, his artificial intelligence company. xAI will pay $45 billion for X, slightly more than Musk paid for it in ...

Elon Musk’s artificial intelligence firm xAI has acquired his social media platform X in an all-stock transaction that values the company at $33 billion, including $12 billion worth of debt ...

Tenya Iida is a member of Deku’s class ... While most of the plot of Hunter x Hunter follows Gon Freecss as he attempts to ...

San Francisco biotechnology Tenaya Therapeutics has shared “encouraging” data from its first patients in the MyPEAK-1 clinical trial of TN-201, despite some concerns over elevations in liver ...